# BioFreedom™ BA9™ Ultra

> **NCT05331547** · — · UNKNOWN · sponsor: **The University of Hong Kong** · enrollment: 50 (estimated)

## Conditions studied

- Cardiovascular Death
- Myocardial Infarction
- Revascularization

## Interventions

- **DEVICE:** BioFreedom BA9 (SS) Ultra DCS

## Key facts

- **NCT ID:** NCT05331547
- **Lead sponsor:** The University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-21
- **Primary completion:** 2022-07-21
- **Final completion:** 2024-01-21
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-04-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05331547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05331547, "BioFreedom™ BA9™ Ultra". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05331547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*